Marsh & McLennan Companies (MRSH) Stock Overview
A professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
MRSH Community Fair Values
Create NarrativeSee what 37 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Marsh & McLennan Companies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$166.18 |
| 52 Week High | US$235.78 |
| 52 Week Low | US$164.89 |
| Beta | 0.75 |
| 1 Month Change | -3.31% |
| 3 Month Change | -11.70% |
| 1 Year Change | -26.89% |
| 3 Year Change | -7.35% |
| 5 Year Change | 20.45% |
| Change since IPO | 6,631.34% |
Recent News & Updates
MRSH: AI Productivity And Balance Sheet Strength Should Support Future Earnings Resilience
Analysts have trimmed the average price target on Marsh & McLennan Companies by about $3 to $203.67, citing a mix of recent target cuts tied to AI disruption concerns and slightly softer growth and margin assumptions, partly balanced by a few upward revisions that highlight the company’s earnings quality and productivity potential. Analyst Commentary Recent research on Marsh & McLennan Companies reflects a split view, with some firms trimming targets and ratings while others still see room for upside after the recent valuation reset.Marsh & McLennan: The Valuation May Finally Be Here
Apr 16Recent updates
MRSH: AI Productivity And Balance Sheet Strength Should Support Future Earnings Resilience
Analysts have trimmed the average price target on Marsh & McLennan Companies by about $3 to $203.67, citing a mix of recent target cuts tied to AI disruption concerns and slightly softer growth and margin assumptions, partly balanced by a few upward revisions that highlight the company’s earnings quality and productivity potential. Analyst Commentary Recent research on Marsh & McLennan Companies reflects a split view, with some firms trimming targets and ratings while others still see room for upside after the recent valuation reset.Marsh & McLennan: The Valuation May Finally Be Here
Apr 16MRSH: Earnings Should Stay Resilient As AI Drives Broker Productivity
The analyst price target for Marsh & McLennan Companies has been trimmed slightly, with a modest reduction of around $1 per share as analysts factor in more tempered assumptions for revenue growth and profit margins, while still highlighting AI driven productivity potential and the resilience of the broker business model. Analyst Commentary Recent research suggests that views on Marsh & McLennan are split, with price targets moving both up and down as analysts reassess growth, margins, and the impact of AI on the broker model.MRSH: Earnings Should Stay Resilient As AI Supports Margins And Productivity
Analyst Price Target Narrative Update The analyst price target for Marsh & McLennan Companies has been adjusted slightly lower, with the updated fair value moving from $207.25 to $207.20 as analysts weigh a mix of reduced targets tied to concerns about AI disruption and softer P&C pricing, against views that the recent selloff may overstate these risks and that AI could support productivity and margins for brokers. Analyst Commentary Recent research shows a divided backdrop for Marsh & McLennan Companies, with price targets clustering in a relatively tight range but ratings spanning Strong Buy through Underperform.MRSH: Earnings Should Stay Resilient Supported By AI And Thrive Productivity Gains
The analyst price target for Marsh & McLennan Companies has edged down by $0.70 to $207.25 as analysts balance cautious views on softer P&C pricing and organic growth headwinds with ongoing margin expansion, strong credit metrics, and benefits tied to digital infrastructure, AI related client spending, and productivity gains from the Thrive initiative. Analyst Commentary Recent research on Marsh & McLennan Companies reflects a split view, with some firms trimming price targets or ratings while others keep a constructive stance despite softer P&C pricing and organic growth headwinds.MRSH: Earnings Should Stay Resilient As Soft P And C Cycle Persists
Narrative Update: Marsh & McLennan Companies (MMC) The updated analyst price target for Marsh & McLennan Companies edges down by about $1 to $207.95, as analysts balance higher assumed revenue growth and margins, along with a slightly lower future P/E, against mixed sector views and a recent valuation reset highlighted in Street research. Analyst Commentary Recent Street research on Marsh & McLennan offers a mixed picture, with some firms lifting ratings or targets and others trimming expectations or staying cautious on sector conditions.MRSH: Future Earnings Should Stay Resilient As P And C Cycle Softens
Analysts have inched their blended price target for Marsh & McLennan Companies up by about $1.70 to roughly $209, reflecting updated assumptions around modestly lower revenue, a slightly higher projected profit margin, and a somewhat lower future P/E multiple. Analyst Commentary Recent research on Marsh & McLennan Companies reflects a mix of optimism and caution, with several firms revisiting their price targets as they refresh sector views and look ahead to 2026.Earnings Update: Marsh & McLennan Companies, Inc. (NYSE:MRSH) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Feb 01
MRSH: Future Earnings Should Prove Resilient As P And C Cycle Softens
Analysts trimmed their blended price target for Marsh & McLennan Companies by about $4 to reflect a slightly lower fair value estimate of $207 per share, citing softer pricing trends in parts of the P&C cycle, emerging growth headwinds for brokers, and a modest reset in future P/E expectations, despite steady margin assumptions. Analyst Commentary Recent Street research shows a fairly balanced split between bullish and bearish voices on Marsh & McLennan, with price targets clustered around the high $100s to low $200s and ratings that range from Underperform to Overweight.MMC: Future Earnings Should Prove Resilient Despite Softer P And C Cycle
Analysts have trimmed their price targets on Marsh & McLennan Companies to a range of around US$200 to US$257 and now see fair value at about US$211.33 per share, reflecting slightly lower revenue growth and profit margin assumptions alongside a modestly higher future P/E. Analyst Commentary Recent Street research on Marsh & McLennan Companies highlights a mix of confidence in the business model and caution around growth, valuation and the broader property and casualty, P&C, cycle.MMC: Future Earnings Will Stay Resilient Despite Softer Property And Casualty Cycle
Analysts have nudged their fair value estimate for Marsh & McLennan Companies slightly lower to approximately $211.62 from $212.35. This reflects broadly reduced Street price targets around $200 to $215 as they factor in softer near term organic growth, a moderating P&C pricing cycle, and a less compelling valuation backdrop.MMC: Future Earnings Will Stay Resilient Amid Softer Property And Casualty Cycle
Analysts have trimmed their price target on Marsh & McLennan Companies to $212.35 from $214.26, reflecting slightly lower medium term growth and margin expectations amid a softer property and casualty backdrop and mixed views on the stock's valuation. Analyst Commentary Recent Street research reflects a more mixed stance on Marsh & McLennan Companies, with modestly reduced price targets offset by a few upward revisions and continued confidence in the company’s earnings quality and balance sheet strength.MMC: Future Earnings Will Remain Stable Despite Sector Volatility And Pricing Headwinds
Marsh & McLennan Companies' average analyst price target has moved modestly lower, reflecting mixed recent results and heightened caution among analysts regarding organic growth trends and sector valuation sensitivity. Analyst Commentary Analyst sentiment on Marsh & McLennan Companies remains mixed following recent quarterly results and ongoing sector volatility.MMC: Earnings Resilience Will Outperform Despite Sector Headwinds And Ongoing Deal Activity
Marsh & McLennan Companies' analyst price target saw a modest reduction of nearly $4 to $214, as analysts cite softer than expected revenue growth and concerns about valuation amidst shifting market dynamics. Analyst Commentary Recent Street research offers a nuanced view of Marsh & McLennan Companies, as analysts weigh market conditions, revenue trends, and valuation pressures.Analyst Commentary Cites Mixed Outlook as Marsh & McLennan Faces Lowered Valuation Targets
Marsh & McLennan Companies' analyst price target has been revised downward by approximately $10 to $218, as analysts adjusted their expectations in light of slower revenue growth and a less attractive valuation in response to ongoing sector headwinds. Analyst Commentary Analysts covering Marsh & McLennan Companies provided a wide range of perspectives in recent research notes, reflecting both positive and cautious outlooks for the company in light of the ongoing sector dynamics, recent earnings trends, and valuation considerations.Global Risk Complexity Will Fuel Advisory Service Demand
Analysts have modestly trimmed their price target for Marsh & McLennan Companies from $232.42 to $228.53. They cited persistent growth headwinds in commercial property pricing and continued sector-wide margin pressures.Marsh & McLennan: Benefiting From Uncertain World
Apr 20Marsh & McLennan: The Serial Acquirer Strikes Again
Feb 11Marsh & McLennan: An Advisory Powerhouse
Dec 17Marsh & McLennan: McGriff Acquisition Is A Good Deal
Sep 30Marsh & McLennan: Hedge For An Uncertain Geopolitical Environment
Aug 22Marsh & McLennan: Insurance Premium Growth Ahead
Jun 06Marsh & McLennan: Scale Advantage And Macro Uncertainty Support Growth Story
Apr 29Marsh & McLennan Q4: Strong Rate Increase, Expect MSD Organic Revenue Growth In FY24
Feb 08Marsh & McLennan: Bullish On Its Double-Digit Growth Across Key Metrics (Upgrade)
Dec 29Marsh & McLennan: Strong Performance Across Economic Cycles
Oct 24Marsh & McLennan Companies: Mix Shift Towards Higher Growth Areas
Sep 13Marsh & McLennan: 3 Reasons To Sell And Take A Capital Gain
Jul 22Marsh & McLennan Q4 2022 Earnings Preview
Jan 25Shareholder Returns
| MRSH | US Insurance | US Market | |
|---|---|---|---|
| 7D | -2.3% | -1.9% | 0.6% |
| 1Y | -26.9% | -5.8% | 28.7% |
Return vs Industry: MRSH underperformed the US Insurance industry which returned -5.8% over the past year.
Return vs Market: MRSH underperformed the US Market which returned 28.7% over the past year.
Price Volatility
| MRSH volatility | |
|---|---|
| MRSH Average Weekly Movement | 4.2% |
| Insurance Industry Average Movement | 4.4% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: MRSH has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: MRSH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1871 | 95,000 | John Doyle | www.corporate.marsh.com/global/home.html |
Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. The company operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services.
Marsh & McLennan Companies, Inc. Fundamentals Summary
| MRSH fundamental statistics | |
|---|---|
| Market cap | US$80.80b |
| Earnings (TTM) | US$3.93b |
| Revenue (TTM) | US$27.52b |
20.4x
P/E Ratio2.9x
P/S RatioIs MRSH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MRSH income statement (TTM) | |
|---|---|
| Revenue | US$27.52b |
| Cost of Revenue | US$15.45b |
| Gross Profit | US$12.07b |
| Other Expenses | US$8.14b |
| Earnings | US$3.93b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.15 |
| Gross Margin | 43.85% |
| Net Profit Margin | 14.26% |
| Debt/Equity Ratio | 139.1% |
How did MRSH perform over the long term?
See historical performance and comparisonDividends
2.2%
Current Dividend Yield45%
Payout RatioDoes MRSH pay a reliable dividends?
See MRSH dividend history and benchmarks| Marsh & McLennan Companies dividend dates | |
|---|---|
| Ex Dividend Date | Apr 09 2026 |
| Dividend Pay Date | May 15 2026 |
| Days until Ex dividend | 23 days |
| Days until Dividend pay date | 13 days |
Does MRSH pay a reliable dividends?
See MRSH dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/01 21:42 |
| End of Day Share Price | 2026/05/01 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Marsh & McLennan Companies, Inc. is covered by 34 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Taylor Scott | Barclays |
| null null | BMO Capital Markets Equity Research |
| Michael Zaremski | BMO Capital Markets Equity Research |